ABSTRACT
Abstract Dasatinib, a potent oral multi-targeted kinase inhibitor against Src and Bcr-Abl, can decrease inflammatory response in sepsis. A simple and cost-effective method for determination of an effective dose dasatinib was established. This method was validated in human plasma, with the aim of reducing the number of animals used, thus, avoiding ethical problems. Dasatinib and internal standard lopinavir were extracted from 180 uL of plasma using liquid-liquid extraction with methyl tert-butil ether, followed by liquid chromatography coupled to triple quadrupole mass spectrometry in multiple reaction monitoring mode. For the pharmacokinetic study, 1 mg/kg of dasatinib was administered to mice with and without sepsis. The method was linear over the concentration range of 1-98 ng/mL for DAS in mice and human plasma, with r2>0.99 and presented intra- and interday precision within the range of 2.3 - 6.2 and 4.3 - 7.0%, respectively. Further intra- and interday accuracy was within the range of 88.2 - 105.8 and 90.6 - 101.7%, respectively. The mice with sepsis showed AUC0-t = 2076.06 h*ng/mL and Cmax =102.73 ng/mL and mice without sepsis presented AUC0-t = 2128.46 h*ng/mL. Cmax = 164.5 ng/mL. The described analytical method was successfully employed in pharmacokinetic study of DAS in mice.
Subject(s)
Animals , Male , Mice , Plasma , Chromatography, Liquid/methods , Tandem Mass Spectrometry/methods , Dasatinib/analysis , PharmacokineticsABSTRACT
O carcinoma mamário é uma doença complexa que engloba diversas alterações genéticas e bioquímicas, além de mudanças no microambiente tumoral, tais como o estresse oxidativo,que pode ocasionar danos estruturais em lipídios, proteínas, bem como no DNA nuclear. O presente estudo teve por objetivo caracterizar o perfil oxidativo de neoplasias mamárias,comparando o perfil de expressão de produtos dos processos de peroxidação lipídica, nitração proteica e oxidação de DNA em função de parâmetros histopatológicos com valor prognóstico quanto à evolução clínica do câncer de mama. (...) Contudo, quando o tamanho tumoral foi analisado separadamente entre tumores Triplo-Negativos ou entre os demais subtipos (Luminal A/B eHER2-like), não se observou efeito significativo sobre a expressão de 8-OHdG. Em conclusão, os dados indicam que alguns tumores Triplo-Negativos são mais resistentes a danos oxidativos sobre DNA, independentemente de grau ou tamanho tumoral, o que pode contribuir para o perfil de maior agressividade deste subtipo tumoral...
Breast cancer is a complex disease that involves multiple genetic and biochemical alterationsand changes in the tumor microenvironment, such as oxidative stress, which can lead tostructural damages to lipids, proteins and nuclear DNA. The present work aimed tocharacterize the oxidative profile of mammary tumors, comparing the products of profileexpression of lipid peroxidation processes, protein nitration and DNA oxidation according tohistopathological parameters with prognostic value as to clinical evolution of breast cancer. (...) However, when the tumor size was analyzed separately from Triple-Negativetumors or among the other subtypes (luminal A / B and HER2-like), there was no significanteffect on the expression of 8-OHdG. In conclusion, the data indicate that some triple-negativetumors are more resistant to oxidative damage over the DNA, regardless of tumor grade orsize, which may contribute to the more aggressive subtype of the tumor...